Sigma-Aldrich Posts 5 Percent Revenue Growth for Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its first-quarter revenues increased 5 percent, with sales for its Research business "slightly higher than expected," according to President and CEO Rakesh Sachdev.

The St. Louis-based chemicals and research products firm reported total sales of $665 million for the three months ended March 31, up 5 percent from $632 million for the first quarter of 2011. On an organic basis, revenues increased 3 percent. It beat Wall Street's consensus estimate of $658.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.